Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Positron Emission Tomography (PET) Radiotracer Market’s Growth Trajectory From 2025 To 2034?

The market size for the positron emission tomography (pet) radiotracer has seen robust growth in recent times. The forecasts suggest a growth from $2.35 billion in 2024, skyrocketing to $2.54 billion in 2025 with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this surge in the historical period include a rise in infectious diseases, expanded awareness and accessibility, the evolution of new radiotracers, an escalation in cancer prevalence, and an increased emphasis on preventive healthcare.

In the coming years, a robust growth is anticipated for the positron emission tomography (pet) radiotracer market, as it’s projected to expand to $3.61 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.2%. The growth during the forecast period is set to be driven by factors such as increased application range, regulatory approval, advancement in emerging markets, the rise of the elderly population, and increasing usage of PET radio scanners. The forecast period is also likely to witness several trends including the evolution of micro-pet technology, integration of wearable technology, the rise of theranostics, development of nano-radiotracers, and the application of blockchain for data security.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Positron Emission Tomography (PET) Radiotracer Market?

Anticipated growth in the positron emission tomography (PET) radiotracer market is being driven by a rise in the prevalence of infectious diseases. These illnesses, identifiable as ones caused by bacteria, viruses, fungi, or parasites, are being further propagated by factors such as climate change, urbanisation, globalisation, antibiotic resistance, and shifts in human behaviours. Using PET radiotracers, healthcare professionals can visualise metabolic activity and inflammation, making it possible to identify infections, gauge treatment efficacy and distinguish between infectious and non-infectious conditions. This aids in securing better results for patients. For instance, the UK Health Security Agency reported an increase of 10.7% in tuberculosis (TB) cases in England in February 2024, with a rise to 4,850 from 4,380 cases in the previous year. The escalating prevalence of infectious diseases is thus expected to drive the growth of the PET radiotracer market.

Which Primary Segments of the Positron Emission Tomography (PET) Radiotracer Market Are Driving Growth and Industry Transformations?

The positron emission tomography (pet) radiotracermarket covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19152&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Positron Emission Tomography (PET) Radiotracer Market?# Market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Positron Emission Tomography (PET) Radiotracer Market?

Established corporations in the positron emission tomography (PET) radiotracer industry are concentrating on the invention of cutting-edge diagnostic tools, like positron emission tomography imaging agents, with an emphasis on increasing cancer detection rates and bettering patient results. A PET imaging agent is essentially a radioactive material used to monitor and analyze biological functions in the body during PET scans. For instance, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical firm located in Canada, introduced Illuccix, also recognized as Ga-68 Gozetotide Preparation Kit (PSMA-11), designed to detect metastatic prostate cancer in Canada in March 2023. This instrument is a crucial resource for medical practitioners to detect metastatic diseases and support in patient management choices. It is recommended for use in patients who are suspected of metastasis and are set for initial definitive therapy, as well as in individuals showing suspected recurrence as indicated by elevated serum prostate-specific antigen (PSA) levels.

View the full report here:

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

What Parameters Are Used to Define the Positron Emission Tomography (PET) Radiotracer Market?

A positron emission tomography (PET) radiotracer refers to a radioactive substance used in positron emission tomography (PET) imaging. A PET radiotracer is utilized by injecting a patient with a radioactive substance that binds to specific biological targets, allowing the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model